undefined

Monica Gandhi

Professor of Medicine at UCSF and Associate Division Chief of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General Hospital. Her expertise lies in HIV research and public health education, and she''s known for her work on low-cost antiretroviral solutions and COVID-19 public outreach.

Top 3 podcasts with Monica Gandhi

Ranked by the Snipd community
undefined
15 snips
Jan 24, 2022 • 2h 53min

#192 - COVID Part 2: Masks, long COVID, boosters, mandates, treatments, and more

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Episode Description: This episode is a follow-up to our recent COVID-19 podcast with Drs. Marty Makary and Zubin Damania (aka ZDoggMD). Here, we address many of the listener questions we received about our original discussion. In addition to Marty and ZDoggMD, we are also joined by Dr. Monica Gandhi, an infectious disease specialist and Professor of Medicine at the University of California, San Francisco. In this episode, we talk about new data on Omicron, long COVID, masks, kids and schools, vaccine mandates, policy questions, and treatments. We also discuss some of the most prevalent misinformation and spend time talking about claims made by Robert Malone. We end with a conversation about our exit strategy.  Please note: we recorded this episode on January 17, 2022, and in an effort to get it out as soon as possible, this won’t have full show notes or a video. Additionally, Monica was only able to join us for the first section of the podcast, so you’ll hear her drop off partway through. We discuss: Severity of infection from Omicron—reviewing the data [5:15]; Factors contributing to the relative mildness of Omicron infections [8:30]; Is SARS-CoV-2 evolving to cause less severe disease? [13:00]; Potential of Covaxin—an inactivated virus-based COVID-19 vaccine [17:45]; How B cells and T cells work together to defend against viruses [22:00]; Comparing COVID-19 vaccines, and the rationale for the time between doses [25:30]; Reviewing the purpose and effectiveness of boosters for reducing severity and transmission [32:30]; Debating vaccine mandates, and putting COVID’s mortality risk in perspective [41:00]; Why the topic of COVID has become so polarized [1:03:15]   Reviewing the data on masks for protecting oneself and protecting others [1:06:30]; The inconsistent logic used for mask mandates [1:16:00];  Long COVID and the potential for vaccines to reduce risk [1:21:45]; Risks for children and policies for schools [1:27:30]; Reviewing the outcomes from Sweden, where the government didn't impose lockdowns [1:31:00]; Draconian measures implemented in Canada [1:38:15];  Antiviral treatments for COVID and a common-sense approach [1:42:15]; Importance of ending tribalism and having rational discussions with humility [1:47:30]; Treating infection with monoclonal antibodies and convalescent sera [2:01:45]; Reviewing claims made by the controversial Dr. Robert Malone [2:11:15]; A potential exit strategy from the current situation [2:30:30]; Changes needed at the NIH [2:40:00]; More. Sign Up to Receive Peter’s Weekly Newsletter Connect With Peter on Twitter, Instagram, Facebook and YouTube
undefined
Oct 14, 2024 • 30min

Dr. Monica Gandhi | Rebuilding Trust in Health Institutions

Dr. Monica Gandhi, a Professor of Medicine at UCSF, dives into the pressing issue of trust in healthcare. She shares insights on the decline in public confidence in major health institutions during the COVID-19 pandemic. The conversation emphasizes the need for clear communication to rebuild trust, tackle vaccine skepticism, and enhance public health compliance. Dr. Gandhi highlights the intersection of individualism and community health, advocating for collective responsibility and compassion in promoting vaccinations and restoring faith in health organizations.
undefined
Oct 14, 2024 • 14min

Preexposure Prophylaxis (PrEP) Options for HIV

Monica Gandhi, an infectious diseases specialist and professor at UCSF, dives into the world of preexposure prophylaxis (PrEP) for HIV. She discusses the alarming rate of new HIV infections globally and the innovative therapies available, including oral medications and the dapivirine ring, which empowers women in HIV prevention. Gandhi emphasizes the critical role of adherence in maximizing PrEP's effectiveness and shares strategies to improve it. She also advocates for primary care doctors to more widely prescribe PrEP, likening it to the adoption of contraception in healthcare.